At Banner Life Sciences™, our business development strategy is to build our presence as a specialty pharmaceutical company with a clear focus on pharmaceutical products, which leverage proprietary technologies and offer real clinical advantages.
The goal of every partnership is to create innovative, demand-driven products that not only provide people with better health solutions but also offer commercial advantages and valuable IP protection for our business partners.
Banner Life Sciences creates value through a number of strategic activities:
In-licensing and acquiring drug formulation technologies that enhance our existing programs in pain, gastroenterology, oncology, and nephrology
In-licensing and acquiring reformulated drug assets where we can create synergies within our current therapeutic areas
In-licensing and acquiring assets in new specialty areas where we can create value by leveraging our existing drug development, clinical, and regulatory expertise
Acquisition of companies that fit within our specialty model, leverage our existing assets and expertise, plus provide us with greater scale.
Out-licensing deprioritized drug development programs